Bio-Techne Corporation (TECH) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology.…
Source: Yahoo Finance
Sector & Industry
Bio-Techne Corporation operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Bio-Techne Corporation at a Glance
| Company | Bio-Techne Corporation |
| Ticker | TECH |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $72.43 |
| Market cap | $11.36B |
| P/E ratio (trailing) | 62.44 |
| EPS (trailing) | $1.16 |
| 52-week high | $72.62 |
| 52-week low | $43.20 |
| Dividend yield | 0.44% |
| Ex-dividend date | 24 Aug 2026 |
| Beta | 1.27 |
| Return on equity (ROE) | 9.03% |
| Debt-to-equity | 13.71% |
| Average volume | 4.72M |
| Shares outstanding | 156.82M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 3,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
- What is Bio-Techne Corporation's current P/E ratio?
- Bio-Techne Corporation (TECH) has a trailing P/E ratio of 62.44 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Bio-Techne Corporation's market capitalisation?
- Bio-Techne Corporation's market cap is $11.36B based on our latest snapshot. See how it ranks by market cap →
- What is TECH's 52-week range?
- Over the past 52 weeks, TECH has traded between $43.20 and $72.62. What does the 52-week range mean? →
- How volatile is Bio-Techne Corporation compared to the market?
- Bio-Techne Corporation has a beta of 1.27, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Bio-Techne Corporation pay a dividend?
- Bio-Techne Corporation's trailing annual dividend yield is 0.44%. Compare with other high-yield stocks →
- What exchange is TECH listed on?
- TECH is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Bio-Techne Corporation in?
- Bio-Techne Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →